The paper mainly describes the changes of tissue factor pathway inhibitor, mechanisms of action and its clinical prospect in ischemic cerebrovascular diseases.

• 文章重点介绍了组织因子途径抑制物在缺血性脑血管病中的变化、作用机制及其临床治疗前景。